» Articles » PMID: 16479563

Evaluation of Sample Size and Power for Multi-arm Survival Trials Allowing for Non-uniform Accrual, Non-proportional Hazards, Loss to Follow-up and Cross-over

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2006 Feb 16
PMID 16479563
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

We present a general framework for sample size calculation in survival studies based on comparing two or more survival distributions using any one of a class of tests including the logrank test. Incorporated within this framework are the possible presence of non-uniform staggered patient entry, non-proportional hazards, loss to follow-up and treatment changes including cross-over between treatment arms. The framework is very general in nature and is based on using piecewise exponential distributions to model the survival distributions. We illustrate the use of the approach and explore its validity using simulation studies. These studies have shown that not adjusting for loss to follow-up, non-proportional hazards or cross-over can lead to significant alterations in power or equivalently, a marked effect on sample size. The approach has been implemented in the freely available program ART (for Stata). Our investigations suggest that ART is the first software to allow incorporation of all these elements. Further extensions to the methodology such as non-local alternatives for the logrank test are also considered.

Citing Articles

Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres.

Fennell D, Griffiths D, Eminton Z, Morgan-Fox A, Hill K, Ewings S BMJ Open. 2023; 13(11):e073120.

PMID: 37993149 PMC: 10668324. DOI: 10.1136/bmjopen-2023-073120.


artbin: Extended sample size for randomized trials with binary outcomes.

Marley-Zagar E, White I, Royston P, Barthel F, Parmar M, Babiker A Stata J. 2023; 23(1):24-52.

PMID: 37461744 PMC: 7614770. DOI: 10.1177/1536867X231161971.


artcat: Sample-size calculation for an ordered categorical outcome.

White I, Marley-Zagar E, Morris T, Parmar M, Royston P, Babiker A Stata J. 2023; 23(1):3-23.

PMID: 37155554 PMC: 7614472. DOI: 10.1177/1536867X231161934.


Surgical or percutaneous coronary revascularization for heart failure: an in silico model using routinely collected health data to emulate a clinical trial.

Pathak S, Lai F, Miksza J, Petrie M, Roman M, Murray S Eur Heart J. 2022; 44(5):351-364.

PMID: 36350978 PMC: 9890210. DOI: 10.1093/eurheartj/ehac670.


Impact of a non-constant baseline hazard on detection of time-dependent treatment effects: a simulation study.

Jachno K, Heritier S, Wolfe R BMC Med Res Methodol. 2021; 21(1):177.

PMID: 34454428 PMC: 8399795. DOI: 10.1186/s12874-021-01372-0.